Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates

被引:686
作者
Berger, Carolina [1 ]
Jensen, Michael C. [2 ]
Lansdorp, Peter M. [3 ,4 ]
Gough, Mike [5 ]
Elliott, Carole [5 ]
Riddell, Stanley R. [1 ,6 ]
机构
[1] Fred Hutchinson Canc Res Ctr, Program Immunol, Seattle, WA 98109 USA
[2] City Hope Natl Med Ctr, Div Canc Immunotherapeut & Tumor Immunol, Duarte, CA 91010 USA
[3] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada
[4] Univ British Columbia, Dept Med, Vancouver, BC V5Z 1M9, Canada
[5] Univ Washington, Natl Primate Ctr, Seattle, WA 98195 USA
[6] Univ Washington, Dept Med, Seattle, WA 98195 USA
关键词
D O I
10.1172/JCI32103
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The adoptive transfer of antigen-specific T cells that have been expanded ex vivo is being actively pursued to treat infections and malignancy in humans. The T cell populations that are available for adoptive immunotherapy include both effector memory and central memory cells, and these differ in phenotype, function, and homing. The efficacy of adoptive immunotherapy requires that transferred T cells persist in vivo, but identifying T cells that can reproducibly survive in vivo after they have been numerically expanded by in vitro culture has proven difficult. Here we show that in macaques, antigen-specific CD8(+) T cell clones derived from central memory T cells, but not effector memory T cells, persisted long-term in vivo, reacquired phenotypic and functional properties of memory T cells, and occupied memory T cell niches. These results demonstrate that clonally derived CD8(+) T cells isolated from central memory T cells are distinct from those derived from effector memory T cells and retain an intrinsic capacity that enables them to survive after adoptive transfer and revert to the memory cell pool. These results could have significant implications for the selection of T cells to expand or to engineer for adoptive immunotherapy of human infections or malignancy.
引用
收藏
页码:294 / 305
页数:12
相关论文
共 51 条
  • [1] Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
    Appay, V
    Dunbar, PR
    Callan, M
    Klenerman, P
    Gillespie, GMA
    Papagno, L
    Ogg, GS
    King, A
    Lechner, F
    Spina, CA
    Little, S
    Havlir, DV
    Richman, DD
    Gruener, N
    Pape, G
    Waters, A
    Easterbrook, P
    Salio, M
    Cerundolo, V
    McMichael, AJ
    Rowland-Jones, SL
    [J]. NATURE MEDICINE, 2002, 8 (04) : 379 - 385
  • [2] Telomere length measurements in leukocyte subsets by automated multicolor flow-FISH
    Baerlocher, GM
    Lansdorp, PM
    [J]. CYTOMETRY PART A, 2003, 55A (01): : 1 - 6
  • [3] Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells
    Becker, TC
    Wherry, EJ
    Boone, D
    Murali-Krishna, K
    Antia, R
    Ma, A
    Ahmed, R
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (12) : 1541 - 1548
  • [4] Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantation
    Berger, C
    Flowers, ME
    Warren, EH
    Riddell, SR
    [J]. BLOOD, 2006, 107 (06) : 2294 - 2302
  • [5] Pharmacologically regulated Fas-mediated death of adoptively transferred T cells in a nonhuman primate model
    Berger, C
    Blau, CA
    Huang, ML
    Iuliucci, JD
    Dalgarno, DC
    Gaschet, J
    Heimfeld, S
    Clackson, T
    Riddell, SR
    [J]. BLOOD, 2004, 103 (04) : 1261 - 1269
  • [6] Nonmyeloablative immunosuppressive regimen prolongs in vivo persistence of gene-modified autologous T cells in a nonhuman primate model
    Berger, C
    Huang, ML
    Gough, M
    Greenberg, PD
    Riddell, SR
    Kiem, HP
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (02) : 799 - 808
  • [7] Cancer immunotherapy: A treatment for the masses
    Blattman, JN
    Greenberg, PD
    [J]. SCIENCE, 2004, 305 (5681) : 200 - 205
  • [8] Molecules and mechanisms of the graft-versus-leukaemia effect
    Bleakley, M
    Riddell, SR
    [J]. NATURE REVIEWS CANCER, 2004, 4 (05) : 371 - 380
  • [9] Cytotoxic T lymphocyte therapy for Epstein-Barr virus Hodgkin's disease
    Bollard, CM
    Aguilar, L
    Straathof, KC
    Gahn, B
    Huls, MH
    Rousseau, A
    Sixbey, J
    Gresik, MV
    Carrum, G
    Hudson, M
    Dilloo, D
    Gee, A
    Brenner, MK
    Rooney, CM
    Heslop, HE
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (12) : 1623 - 1633
  • [10] Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15
    Brentjens, RJ
    Latouche, JB
    Santos, E
    Marti, F
    Gong, MC
    Lyddane, C
    King, PD
    Larson, S
    Weiss, M
    Rivière, I
    Sadelain, M
    [J]. NATURE MEDICINE, 2003, 9 (03) : 279 - 286